首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >100 Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3 Randomized Double‐Blind Placebo‐Controlled EVOLVE‐1 and EVOLVE‐2 Studies

【2h】

100 Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3 Randomized Double‐Blind Placebo‐Controlled EVOLVE‐1 and EVOLVE‐2 Studies

机译：发作性偏头痛患者对Galcanezumab的100％反应率：对3期随机双盲安慰剂对照EVOLVE-1和EVOLVE-2研究的结果进行事后分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo characterize adult patients with episodic migraine who achieved 100% response to galcanezumab treatment.

机译：目的鉴定成年发作性偏头痛患者对加仑单抗治疗有100％反应的特征。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Noah Rosen; Eric Pearlman; Dustin Ruff; Kathleen Day; Abraham Jim Nagy;
展开▼
作者单位

展开▼
年(卷),期 -1(58),9
年度 -1
页码 1347–1357
总页数 11
原文格式 PDF
正文语种
中图分类
关键词
migraine prevention galcanezumab CGRP 100 response;

机译：偏头痛;预防;加那珠单抗;CGRP;100％反应;

相似文献

外文文献
中文文献

1. 100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1 and EVOLVE‐2 Studies [J] . Rosen Noah, Pearlman Eric, Ruff Dustin, Headache . 2018,第Suppla2期

机译：患有11例患者的100％对加葫芦患者的反应率：HOC对第3阶段，随机，双盲，安慰剂控制的演出-1和进化-2研究的结果
2. 100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1 and EVOLVE‐2 Studies [J] . Rosen Noah, Pearlman Eric, Ruff Dustin, Headache . 2018,第9期

机译：患有11例患者的100％对加葫芦患者的反应率：HOC对第3阶段，随机，双盲，安慰剂控制的演出-1和进化-2研究的结果
3. Evaluation of Cardiovascular Outcomes in Adult Patients With Episodic or Chronic Migraine Treated With Galcanezumab: Data From Three Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1, EVOLVE‐2, and REGAIN Studies [J] . Oakes Tina M., Kovacs Richard, Rosen Noah, Headache . 2020,第1期

机译：用Galcanezumab治疗的成年患者成年患者心血管结果评估：三相3，随机，双盲，安慰剂控制的进化-1，进化-2和重新研究
4. EFFECT OF TARGETED PULSED ELECTROMAGNETIC FIELD THERAPY ON CANINE POST-OPERATIVE HEMILAMINECTOMY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL [C] . ACVS Veterinary Symposium . 2018

机译：靶向脉冲电磁场治疗对犬术后血栓切除术的影响：双盲，随机，安慰剂对照临床试验
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Impact of galcanezumab on total pain burden: findings from phase 3 randomized double-blind placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1 EVOLVE-2 and REGAIN trials) [O] . Jessica Ailani, J. Scott Andrews, Mallikarjuna Rettiganti, 2020

机译：Galcanezumab对总疼痛负担的影响：从第3阶段随机双盲安慰剂对照研究患者患者（演化-1进化-2和Regain试验）
7. Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies [O] . Todd A. Smitherman, Gretchen E. Tietjen, Kory Schuh, 2020

机译：Galcanezumab对焦虑和/或抑郁症病史患者偏头痛预防的疗效：第3阶段的后HOC分析，随机，双盲，安慰剂控制的恢复，并汇集演变-1和进化2研究

100 Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3 Randomized Double‐Blind Placebo‐Controlled EVOLVE‐1 and EVOLVE‐2 Studies

摘要

著录项

相似文献

相关主题

期刊订阅